Protecting Patient Access to Lifesaving COVID–19 Drugs Act of 2021
Active· Referred to the Subcommittee on Health.
Introduced
Jan 25, 21
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending
Introduced
Jan 25, 21
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending
Executive Summary
Protecting Patient Access to Lifesaving COVID-19 Drugs Act of 2021
This bill requires health insurance plans to cover COVID-19 (i.e., coronavirus disease 2019) antibody treatment at no cost for individuals who have tested positive for the virus.
Action Timeline
7
FEB 02, 2021•Committee
Referred to the Subcommittee on Health.
JAN 25, 2021•IntroReferral
Introduced in House
JAN 25, 2021•IntroReferral
Introduced in House
JAN 25, 2021•Committee
Referred to the Subcommittee on Health.
JAN 25, 2021•IntroReferral
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
JAN 25, 2021•IntroReferral
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
JAN 25, 2021•IntroReferral
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.